Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Non-Hodgkin Lymphoma
This book provides clinical practitioners and the research community with detailed information on the diagnosis, prognosis, and treatment of non-Hodgkin lymphoma, taking into account the significant growth in knowledge including multiple therapeutic advances that have been achieved over the past 5-10 years. The work is subdivided into epidemiology, pathogenesis, pathology, imaging, and therapy of the non-Hodgkin lymphomas. The full range of therapeutic options are examined according to the major subtypes of non-Hodgkin lymphoma and the most up-to-date information is provided on current standard treatment options, including stem cell transplantation as well as new cutting-edge therapeutics.
Fast Facts: Lymphoma
Lymphomas arise from a single abnormal lymphocyte, yet many different subtypes of lymphoma occur. Recent advances in cellular and molecular techniques have revolutionized physicians' understanding of this malignancy, and there have been dramatic developments in diagnosis and treatment.Fast Facts: Lymphoma gives a comprehensive and up-to-date perspective on this challenging disease written by three experts in the field. Starting with a clear outline of the nature of lymphoma, its diagnosis, staging and management, this concise handbook goes on to provide specific details of individual lymphoma entities and treatment modalities.Fast Facts: Lymphoma is a valuable handbook for training doctors and specialist nurses working in the field of hemato-oncology, and will be of interest to the inquiring patient or carer who wishes to know more about lymphoma.
Non-Hodgkin Lymphoma
This book provides clinical practitioners and the research community with detailed information on the diagnosis, prognosis, and treatment of non-Hodgkin lymphoma, taking into account the significant growth in knowledge including multiple therapeutic advances that have been achieved over the past 5-10 years. The work is subdivided into epidemiology, pathogenesis, pathology, imaging, and therapy of the non-Hodgkin lymphomas. The full range of therapeutic options are examined according to the major subtypes of non-Hodgkin lymphoma and the most up-to-date information is provided on current standard treatment options, including stem cell transplantation as well as new cutting-edge therapeutics.
Handbook of Advanced Cancer Care
Patients with advanced cancer increasingly receive end-of-life care from a variety of health care professionals, physicians and nurses. These professionals need to be able to assess the original diagnosis and the appropriateness of patient referral, set a treatment or palliation program, and recognise and plan for the clinical problems associated with specific primary tumors. This is the first comprehensive source of information available at a level between specialist oncology texts and nursing texts. Two eminent physicians from one of the world's foremost cancer centers have drawn together a remarkable team to provide a handbook which covers the full range of problems the healthcare workforce caring for these patients will encounter. This highly accessible text covers general principles in oncology, the primary tumors one by one, and management of specific symptoms and syndromes. It will be invaluable to primary care physicians, surgeons, nurses, therapists and trainees.
Conn's Current Therapy 2012
Conn's Current Therapy 2012, by Drs. Edward T. Bope and Rick D. Kellerman, offers you expert guidance on the latest therapeutic options for common and not-so-common health concerns. Hundreds of international contributors provide evidence-based management options to help you make more effective diagnoses and achieve the best outcomes. Find what you need quickly and easily with a totally reworked organization of topics, and keep current with updated material throughout, including brand-new chapters on fatigue and migraines. This practical guide, with its searchable online content at www.expertconsult.com, is your ideal way to learn and apply the latest, most effective therapeutic approaches. G...
Conn's Current Therapy 2011
Conn’s Current Therapy 2011 is an easy-to-use, in-depth guide to the latest advances in therapeutics for common complaints and diagnoses. Drs. Edward T. Bope, Rick D. Kellerman, and Robert E. Rakel present the expertise and knowledge of hundreds of skilled international leaders on the full range of evidence-based management options. With coverage of recent developments in travel medicine, sleep apnea, and immunization practices, as well as standardized diagnostic points and clinical recommendation tables, you’ll have access to the information you need. Deliver effective treatment after making correct diagnoses through discussions of important diagnostic criteria in each chapter. Get the ...
Lymphoma
Major advances have occurred in the diagnosis and treatment of lymphoma in recent years. Our understanding of the molecular biology and genetics of the disease has increased exponentially, and significant imaging developments have resulted in earlier and more accurate diagnosis. The new edition of this landmark text places these advances in the context of daily clinical practice. Each chapter has been updated to reflect recent developments, including new treatment agents such as immunomodulatory drugs and the next generation of antibodies, and the increasing prognostic role of PET scanning. Results from recent large-scale clinical trials are presented, and pathology and cytogenetics are integrated into discussion of each disease entity, enabling the reader to review all the key diagnostic information in one place. Featuring many color illustrations, and written and edited by leading authorities in the field, Lymphoma provides all the information you need to diagnose and manage these complex disorders.
Hodgkin's and Non-Hodgkin's Lymphoma
In recent years a dramatic increase in knowledge of the biology of the lymphomas has been accompanied by the emergence of new treatments offering improvements in efficacy and reduction in toxicity. In this volume an internationally recognized group of experts review relevant aspects of the biology, diagnosis and management, with particular emphasis on the emerging data available for this disease.
Hodgkin Lymphoma
This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
Adult Acute Lymphocytic Leukemia
The current explosion of new areas of controversy in the treatment of acute lymphocytic leukemia in adults and young adults makes this comprehensive book a much needed reference for hematologists and oncologists. This book assembles leading authorities from around the globe to cover the full spectrum of ALL subtypes and their treatments. Specific topics of discussion include indications for allogeneic bone marrow transplant in first complete remission, the role of minimal residual disease in making treatment decisions, the treatment of young adults, and the treatment of Philadelphia chromosome positive ALL with the advent of the tyrosine kinase inhibitors. This is the first book to focus exclusively on the adult ALL patient. It provides a complete overview of diagnosis, molecular pathogenesis, evaluation, and treatment for this important patient population.
